Insider Transactions in Q3 2024 at Monopar Therapeutics (MNPR)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,918
-3.3%
|
$11,508
$6.74 P/Share
|
|
Sep 30
2024
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,895
+7.77%
|
-
|
|
Sep 30
2024
|
Andrew Cittadine Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
535
-1.32%
|
$3,210
$6.74 P/Share
|
|
Sep 30
2024
|
Andrew Cittadine Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,791
+4.24%
|
-
|